This contract expires in 330 days (Sep 19, 2027).

DUKE UNIVERSITY - NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE

PIID: 75N94025F00002

Signed Date: Jul 25, 2025Effective Date: Sep 20, 2025End Date: Closes in 330 days

Award $

$5.0M

Vendor

DUKE UNIVERSITY

NAICS

541715

Signed Date

Jul 25, 2025

Key Details

Dollars Obligated

$5.0M

Base & All Options

$14.8M

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Parent IDIQ (PIID)

75N94025D00003

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

DURHAM, NC

NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE

On Jul 25, 2025, Department of Health and Human Services obligated $4,996,765.7 to DUKE UNIVERSITY for nichd: r&d: bpca pediatric drug development clinical trial infrastructure: severable. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Sep 19, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.